ASX-Listed Oncology Biotech The CompanyOur client is an innovative ASX-listed biotechnology company based in inner Melbourne, with more than 20 years experience advancing proprietary dendrimer technology from discovery to clinical application. Its mission is to improve outcomes for patients with serious illnesses, particularly cancer, by developing novel dendrimer-based therapies. The company has achieved strong clinical validation across multiple Phase 2 oncology programs and is advancing ...
Biotech Drug Development Clinical Programs The CompanyDimerix Limited (ASX: DXB), is a Melbourne-based clinical-stage biopharmaceutical company developing patient-preferred treatments for unmet needs in kidney and inflammatory diseases. Its pipeline includes lead asset DMX-200 for FSGS, diabetic kidney disease and ARDS, and DMX-700 for COPD. Working with global partners, CROs, CDMOs and specialist consultants, Dimerix is a small, collaborative, values-led team at an exciting stage of clinical ...
Insert additional messaging here.
